台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-華南永昌-基隆 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1001/2202/1402/2803/1203/2404/0604/1604/2805/0805/10405060708090Jul '24Sep '24Nov '24Mar '25May '2560d90dAll

華南永昌-基隆 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0900.00266.3065.00-2495-0.40%
2025/05/0800.00564.7067.30-5491-1.02%
2025/05/07766.20166.0065.9064811.25%
2025/04/2900.00362.5062.50-3464-0.65%
2025/04/24656.2000.0056.5064671.28%
2025/04/22155.8000.0055.5014710.21%
2025/04/15260.3500.0060.1024900.41%
2025/04/1100.00158.7059.20-1493-0.20%
2025/04/0800.00155.3055.40-1486-0.21%
2025/04/02166.8000.0066.6015050.20%
2025/03/3100.00268.0067.50-2561-0.36%
2025/03/1200.00177.7077.50-1585-0.17%
2025/03/11175.601.283.3381.50-0.2557-0.04%
2025/03/1000.00275.1076.80-2518-0.39%
2025/02/26166.5000.0066.4014900.20%
2025/02/2500.00268.3067.70-2503-0.40%
2025/02/2000.00270.8071.00-2497-0.40%
2025/02/17162.1000.0062.2015210.19%
2025/02/1200.00163.4061.90-1585-0.17%
2025/02/11163.8000.0064.0015940.17%
2025/01/13164.4000.0062.8016270.16%
2024/12/26769.8000.0066.6076921.01%
2024/12/25275.3000.0074.0026830.29%
2024/12/201660.5300.0060.40166842.34%
2024/12/1800.001060.9060.90-10678-1.47%
2024/12/1200.00256.5054.90-2678-0.29%
2024/12/11354.9000.0054.9036660.45%
2024/12/06165.0000.0064.3016510.15%
2024/11/26269.0000.0068.6026810.29%
2024/11/25171.0000.0071.9016810.15%
2024/11/2200.00771.6073.00-7672-1.04%
2024/11/201067.0000.0067.40106661.50%
2024/11/1400.00167.2069.00-1670-0.15%
2024/11/13166.0000.0064.0016520.15%
2024/11/12165.5000.0070.0016320.16%
2024/11/11870.10271.0070.1066060.99%
2024/11/08177.7000.0077.8016030.17%
2024/11/06285.00285.9085.2006340.00%
2024/11/05486.50285.8084.9026360.31%
2024/10/240.2103.0000.00102.500.26970.03%
2024/10/1811115.181114.00110.00107681.30%
2024/10/093119.502119.00119.0018380.12%
2024/10/0800.001127.50126.00-1839-0.12%
2024/10/0700.001117.00116.50-1830-0.12%
2024/10/0400.003105.00106.50-3813-0.37%
2024/10/01197.2000.0097.2017870.13%
2024/09/302108.000.1108.00108.0027770.25%
2024/09/277120.711126.50120.0067960.75%
2024/09/268137.560.9134.12133.007.17850.90%
2024/09/1100.001182.50185.00-1792-0.13%
2024/09/101195.001195.00183.0008120.00%
2024/09/091190.0000.00195.0018080.12%
2024/08/281216.5000.00210.0017880.13%
2024/08/2700.001218.50220.00-1785-0.13%
2024/08/2000.001214.00216.00-1806-0.12%
2024/08/191193.5000.00201.5018200.12%
2024/08/1400.000.2191.33192.00-0.2841-0.02%
2024/08/125198.401200.00198.0048350.48%
2024/08/091201.007203.57203.50-6824-0.73%
2024/08/0800.001.1185.09187.00-1.1794-0.14%
2024/08/062181.506175.33171.00-4777-0.51%
2024/08/0500.002174.00180.00-2768-0.26%
2024/07/265150.006150.00148.00-1700-0.14%
2024/07/2300.002.1162.95160.00-2.1685-0.31%
2024/07/221164.009164.11164.00-8667-1.20%
2024/07/1900.002.2178.23182.00-2.2650-0.34%
2024/07/183194.171191.50196.5026110.33%
2024/07/171189.502191.00191.00-1589-0.17%
2024/07/162169.0000.00174.5025660.35%
2024/07/1500.002167.00164.50-2554-0.36%
2024/07/1200.001153.00162.00-1544-0.18%
2024/07/112154.0000.00149.0025310.38%
2024/07/1000.002147.00152.50-2512-0.39%
2024/07/034124.501125.50124.5034740.63%
2024/07/023136.6700.00138.0034460.67%
2024/07/012137.0000.00137.5024350.46%
2024/06/2800.003.8130.00130.00-3.8413-0.93%
2024/06/2100.001107.50106.00-1368-0.27%
2024/06/0700.00297.5098.10-2320-0.62%
2024/06/0600.00195.4095.00-1318-0.31%
2024/05/29295.651101.5094.5013190.31%
2024/05/2800.001.6100.72100.00-1.6312-0.53%
2024/05/22195.0000.0091.5012600.38%
2024/05/21193.0000.0093.0012500.40%
2024/05/1600.00375.0075.00-3226-1.32%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音